Dechra Pharmaceuticals Plc

Dechra Pharmaceuticals (DPH)

Buy
Sell
Company name:Dechra Pharmaceuticals Plc
EPIC:DPHTrading Currency:GBX
Market Sector:F25FISIN:GB0009633180
Market Segment:STMMShare Type:DE
WWW Address:http://www.dechra.com/Description:ORD 1P
Industry Sector:PHARMACEUTICALS & BIOTECHNOLOGY
 Price Price Change [%] Bid Offer Open High Low Volume
 3,498.00 images.advfn.com/imagesnew/2/gb/dot 0.0 [0.00] 3,498.00 3,502.00 3,534.00 3,534.00 3,478.00 33,949
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 3,789.17 108.32 0.68 32.87 34.29 106.42 0.98 3,534.00 - 2,030.00

Dechra Pharmaceuticals Key Figures

(at previous day's close)
Market Cap.3,789.17m
Shares In Issue108.32m
Prev. Close3,498.00
PE Ratio106.42 
Dividend Yield0.98%
EPS - basic32.87p
Dividend PS34.29p
Dividend Cover0.96 
Cash Flow PS98.22p
Return On Equity (ROE)5.32%
Operating Margin7.94%
PEG Factor11.80 
EPS Growth Rate9.02%
Dividends PS Growth Rate8.51%
Net Debt372.70m
Gross Gearing48.49%
Quick Assets330.80m
Net Working Capital314.30m
Intangibles / Fixed Assets88.07%
Turnover PS475.52p
Pre-Tax Profit PS37.76p
Retained Profit PS0.55p
Cash PS209.93p
Net Cash PS83.18p
Net Tangible Asset Value PS *-50.50p
Net Asset Value PS588.51p
Spread4.00 (0.11%) 

Dechra Pharmaceuticals Balance Sheet

LSE:DPH:Liabilities+EQLSE:DPH:Assets

Share Price Performance

Sample Period HighLow
1 week3,534.003,342.00
4 weeks3,534.003,128.00
12 weeks3,534.002,832.00
1 year3,534.002,030.00

Share Price Chart (5 years)

Dechra Pharmaceuticals Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week3,438.0060.001.753,342.000.393,450.57
4 weeks3,202.00296.009.243,128.000.343,311.28
12 weeks2,898.00600.0020.702,832.000.293,225.62
26 weeks2,712.00786.0028.982,552.000.332,986.36
1 year2,614.00884.0033.822,030.000.332,826.04
3 years2,040.001,458.0071.471,956.000.302,623.50
5 years939.502,558.50272.33811.000.242,307.35

Dechra Pharmaceuticals Key Management Ratios

Dechra Pharmaceuticals Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio94.53 
PE Ratio106.42 
Tobin's Q Ratio 3.31 
Tobin's Q Ratio (excl. intangibles)8.36 
Dividend Yield0.98%
Market-to-Book Ratio5.94 
Price-to-Pre-Tax Profit PS92.64 
Price-to-Retained Profit PS6,315.28 
Price-to-Cash Flow PS35.61 
Price-to-Sales PS7.36 
Price-to-Net Tangible Asset Value PS-69.27 
Price-to-Cash PS16.66 
Net Working Capital PS290.15 
Price Pct to Working Capital PS12.06%
Earnings Yield0.94%
Average PE79.09 
Years in average5 
PE to PE average134.56%

Dechra Pharmaceuticals Financial Ratios

(Leverage Ratios)
Debt Ratio42.06%
Debt-to-Equity Ratio0.73 
Debt-to-Equity Ratio (excl. Intgbl)-8.46 
Debt-to-Equity Market Value0.12 
Net Gearing30.11%
Net Gearing (excl. Intangibles)68.34%
Gross Gearing48.49%
Gross Gearing (excl. Intangibles)110.03%
Gearing Under 1 Year11.09%
Gearing Under 1 Year (excl. Intgbl)25.17%
Assets/Equity1.94 
Cash/Equity35.67 
(Liquidity Ratios)
Net Working Capital to Total Assets25.40%
Current Ratio3.29 
Quick Ratio (Acid Test)2.41 
Liquidity Ratio1.66 
Cash & Equiv/Current Assets50.35%
(Solvency Ratios)
Enterprise Value4,024.57m
CFO/Sales0.21 
CFO/Attributable Profit3.14 
CFO/Assets0.09 
CFO/Debt0.18 
Total Debt/Equity Market Value0.16 
Total Debt/Sales1.17 
Total Debt/Pre-Tax Profit14.67 
Total Debt600.10m
Total Debt/Net Current Assets1.91%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth18.61%
10 yr Compound Earnings Growth4.42%
Earn drops > 5% in 10yrs6 
Beta (60-Mnth)Beta (36-Mnth)
0.6769-0.1689

Dechra Pharmaceuticals Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)3.72%
Return On Assets (ROA)2.97%
Net Profit Margin6.58%
Assets Turnover0.45 
Return On Equity (ROE)5.32%
Return On Investment (ROI)3.34%
Dividend Payout Ratio104.32%
Plowback Ratio-4.32%
Growth from Plowback Ratio-0.26%
Net Income Of Revenues0.12%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.90 
Fixed Assets Turnover0.67 
Current Assets Turnover1.38 
Net Working Capital Turnover 
Inventory Turnover4.58 
(Other Operating Ratios)
Total Assets-to-Sales2.22 
Debtors-to-Sales20.59%
Debt Collection Period75.15Days

Dechra Pharmaceuticals Dividends

Announcement DateTypeCurr.Dividend AmountPeriod StartPeriod EndEx DateRecord DatePayment DateTotal Dividend Amount
07 Sep 2020FinalGBX24.0030/06/201930/06/202005/11/202006/11/202027/11/202034.29
24 Feb 2020InterimGBX10.2930/06/201930/06/202005/03/202006/03/202008/04/2020-
02 Sep 2019FinalGBX22.1030/06/201830/06/201924/10/201925/10/201915/11/201931.60
25 Feb 2019InterimGBX9.5030/06/201830/06/201907/03/201908/03/201908/04/2019-
03 Sep 2018FinalGBX18.1730/06/201730/06/201825/10/201826/10/201816/11/201825.50
26 Feb 2018InterimGBX7.3330/06/201730/06/201808/03/201809/03/201806/04/2018-
04 Sep 2017FinalGBX15.3330/06/201630/06/201726/10/201727/10/201717/11/201721.44
27 Feb 2017InterimGBX6.1130/06/201630/06/201709/03/201710/03/201707/04/2017-
05 Sep 2016FinalGBX12.9130/06/201530/06/201627/10/201628/10/201618/11/201618.46
22 Feb 2016InterimGBX5.5530/06/201530/06/201610/03/201611/03/201606/04/2016-
07 Sep 2015FinalGBX11.8230/06/201430/06/201529/10/201530/10/201520/11/201516.94
23 Feb 2015InterimGBX5.1230/06/201430/06/201512/03/201513/03/201507/04/2015-
08 Sep 2014FinalGBX10.6530/06/201330/06/201406/11/201407/11/201421/11/201415.40
25 Feb 2014InterimGBX4.7530/06/201330/06/201412/03/201414/03/201408/04/2014-
03 Sep 2013FinalGBX9.6630/06/201230/06/201306/11/201308/11/201322/11/201314.00
26 Feb 2013InterimGBX4.3430/06/201230/06/201313/03/201315/03/201309/04/2013-
04 Sep 2012FinalGBX8.5030/06/201130/06/201207/11/201209/11/201223/11/201212.60
21 Feb 2012InterimGBX4.1030/06/201130/06/201207/03/201209/03/201210/04/2012-
06 Sep 2011FinalGBX8.4030/06/201030/06/201109/11/201111/11/201125/11/201112.10
22 Feb 2011InterimGBX3.7030/06/201030/06/201109/03/201111/03/201107/04/2011-
07 Sep 2010FinalGBX7.2030/06/200930/06/201010/11/201012/11/201010/12/201010.50
23 Feb 2010InterimGBX3.3030/06/200930/06/201003/03/201005/03/201001/04/2010-
01 Sep 2009FinalGBX6.1030/06/200830/06/200911/11/200913/11/200911/12/20099.10
02 Sep 2008FinalGBX2.7530/06/200730/06/200812/11/200814/11/200812/12/2008-
25 Feb 2007InterimGBX2.5001/07/200631/12/200607/03/200709/03/200710/04/2007-
05 Sep 2006FinalGBX4.3330/06/200530/06/200625/10/200627/10/200624/11/20066.24
28 Feb 2006InterimGBX1.9101/07/200531/12/200508/03/200610/03/200607/04/2006-
06 Sep 2005FinalGBX3.5030/06/200430/06/200526/10/200528/10/200525/11/20055.20
01 Mar 2005InterimGBX1.7001/07/200431/12/200409/03/200511/03/200507/04/2005-
07 Sep 2004FinalGBX3.1530/06/200330/06/200427/10/200429/10/200424/11/20044.70
02 Mar 2004InterimGBX1.5501/07/200331/12/200310/03/200412/03/200407/04/2004-
02 Sep 2003FinalGBX2.7530/06/200230/06/200329/10/200331/10/200326/11/20034.12
04 Mar 2003InterimGBX1.3701/07/200231/12/200212/03/200314/03/200309/04/2003-
03 Sep 2002FinalGBX2.7530/06/200130/06/200229/10/200201/11/200227/11/20024.12
26 Feb 2002InterimGBX1.3701/07/200131/12/200106/03/200208/03/200208/04/2002-
04 Sep 2001FinalGBX2.5030/06/200030/06/200131/10/200102/11/200128/11/20013.75
28 Feb 2001InterimGBX1.2501/07/200031/12/200007/03/200109/03/200104/04/2001-

Dechra Pharmaceuticals Fundamentals

 30 Jun 2017 (GBP)30 Jun 2018 (GBP)30 Jun 2019 (GBP)30 Jun 2020 (GBP)
turnover359.28100.00%407.10100.00%481.80100.00%515.10100.00%m
pre tax profit28.567.95%28.907.10%27.805.77%40.907.94%m
attributable profit26.117.27%36.108.87%30.906.41%33.906.58%m
retained profit8.442.35%14.303.51%2.500.52%0.600.12%m
eps - basic (p)28.09 37.24 30.15 32.87 
eps - diluted (p)27.93 37.04 30.07 32.76 
dividends per share21.44 25.50 31.60 34.29 

Dechra Pharmaceuticals Balance Sheet

 30 Jun 2017 (GBP)30 Jun 2018 (GBP)30 Jun 2019 (GBP)30 Jun 2020 (GBP)
LSE:DPH:Liabilities+EQLSE:DPH:AssetsLSE:DPH:Liabilities+EQLSE:DPH:AssetsLSE:DPH:Liabilities+EQLSE:DPH:AssetsLSE:DPH:Liabilities+EQLSE:DPH:Assets
 30 Jun 2017 (GBP)30 Jun 2018 (GBP)30 Jun 2019 (GBP)30 Jun 2020 (GBP)
ASSETS
fixed assets fixed assets45.207.08%45.304.45%58.405.57%76.406.17%m
intangibles intangibles396.2662.10%709.8069.77%687.0065.52%692.2055.93%m
fixed investments fixed investments10.851.70%10.501.03%10.100.96%17.401.41%m
current assets - other current assets - other--%--%--%--%m
stocks stocks56.518.86%86.608.51%104.009.92%120.809.76%m
debtors debtors68.0510.66%85.408.39%108.7010.37%103.408.35%m
cash & securities cash & securities61.209.59%79.707.83%80.307.66%227.4018.37%m
TOTAL638.07100%1,017.30100%1,048.50100%1,237.60100%m
LIABILITIES
creditors - short creditors - short66.4110.41%91.609.00%118.1011.26%137.3011.09%m
creditors - long creditors - long269.0242.16%420.7041.35%421.3040.18%462.8037.39%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
TOTAL335.4352.57%512.3050.36%539.4051.44%600.1048.49%m
EQUITY
ord cap, reserves ord cap, reserves301.0747.19%505.0049.64%509.1048.56%637.5051.51%m
prefs, minorities prefs, minorities1.560.24%--%--%--%m
TOTAL302.6447.43%505.0049.64%509.1048.56%637.5051.51%m
OTHER
NAV Basic- - - - 
NAV Diluted- - - - 

Dechra Pharmaceuticals Cash Flow Statement

30 Jun 2017 (GBP)30 Jun 2018 (GBP)30 Jun 2019 (GBP)30 Jun 2020 (GBP)
Operating CF77.4364.0081.80106.40m
Pre-Financing CF20.15-177.7019.9024.90m
Retained CF21.7416.10-0.20143.80m

Dechra Pharmaceuticals Brokers

NameActivityTypeMnemonicCode
Commerzbank AGMarket Maker(MME)Broker/DealerKLWTDRESGB2LPST
Evolution Securities LimitedMarket Maker(MME)Broker/DealerEVOEVBGGB21MMT
Investec Bank PlcMarket Maker(MME)Broker/DealerINV.IHCSGB21002
Morgan Stanley Securities LtdMarket Maker(MME)Broker/DealerMOSTMSSEGB21
Numis Securities LimitedMarket Maker(MME)Broker/DealerNUMSRAZHGB2LBIC
Shore Capital Stockbrokers LtdMarket Maker(MME)Broker/DealerSCAPSHOCGB21
Merrill Lynch InternationalMarket Maker(MME)Broker/DealerMLSBSNCSGB2LBIC
Winterflood Securities LtdMarket Maker(MME)Broker/DealerWINSWNTSGB2LBIC
ADVFN Advertorial
Your Recent History
LSE
DPH
Dechra Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20201021 07:43:45